CRISPR is a gene editing tool that allows for the addition, removal, or alteration of DNA, including in human cells. It can greatly accelerate research and has potential uses in a variety of organisms from mosquitoes to human beings. In this webinar, we will trace the international and U.S. policy and ethics responses to CRISPR technology use in humans, noting how those responses compare with past responses to related technologies.
Language Availability: English
Suggested Audiences: Institutional Review Board (IRB) members, Bioethicists, IRB/HRPP Administrators and Staff, Researchers, Research Team Members, Institutional/Signatory Officials, IRB Chairs, Students
Organizational Subscription Price: $300 per year/per site or included as part of the $1,000 annual subscription to our All Access Webinar Package
Independent Learner Price: $49 per person
Ethics & Policy Issues in CRISPR Gene Editing
Presented by: Josephine Johnston – The Hastings Center
In this webinar, we explore the ethical and policy issues associated with CRISPR gene editing. The webinar begins with an introduction to CRISPR, including comparing it to existing gene editing and gene transfer technologies. It continues with a discussion on the laws, regulations, and recommendations affecting use of gene editing technologies in humans (and the commensurate ethical objections to use of these technologies to make heritable changes to human babies). In looking toward the future, the webinar concludes with a discussion on the ethics and policy questions that are likely to receive attention from international and national policymakers.
Recommended Use: Required
ID (Language): 19647 (English)